It is a logical rationale
Period! says George Hajduczok, a medical device and pharmaceutical product liability and regulatory affairs attorney in Buffalo, New York
These results support the continued safe use of GLP-1 RAs in T2DM and obesity, although longer trials with cancer-specific endpoints are warranted
Diabetes, obesity, and gastrointestinal side effects are possible culprits for insomnia while on Ozempic
You can eat after injecting GLP-1 medications like semaglutide, but your appetite and digestive comfort may differ significantly from before treatment
Histamine-N-Methyltransferase (HNMT) This enzyme works inside cells, including in your brain, bronchial tissues, and skin